Foreign-Trade Zone (FTZ) 153-San Diego, California, Notification of Proposed Production Activity, Ajinomoto Bio-Pharma Services (Pharmaceutical Products), San Diego, California, 56626 [2022-19897]
Download as PDF
<![CDATA[
56626
Federal Register / Vol. 87, No. 178 / Thursday, September 15, 2022 / Notices
Notice of Public Meeting of the
California Advisory Committee
AGENCY:
U.S. Commission on Civil
Rights.
ACTION: Announcement of meeting.
Notice is hereby given,
pursuant to the provisions of the rules
and regulations of the U.S. Commission
on Civil Rights (Commission) and the
Federal Advisory Committee Act that
the California Advisory Committee
(Committee) will hold a meeting via a
Webex platform on Wednesday, October
12, 2022, from 1:30 p.m. to 3 p.m., for
the purpose of discussing their current
project on the civil rights implications
of AB5.
DATES: The meeting will take place on:
• Wednesday, October 12, 2022, from
1:30 p.m.–3 p.m. Pacific time.
Webex Registration Link: https://
tinyurl.com/3mwxm7m9.
FOR FURTHER INFORMATION CONTACT:
Brooke Peery, Designated Federal
Officer (DFO), at bpeery@usccr.gov or by
phone at (202) 701–1376.
SUPPLEMENTARY INFORMATION: Members
of the public may listen to the
discussion. This meeting is available to
the public through the public WebEx
registration link listed above. An open
comment period will be provided to
allow members of the public to make a
statement as time allows. Persons with
hearing impairments may also follow
the proceedings by first calling the
Federal Relay Service at 1–800–877–
8339.
Members of the public are also
entitled to submit written comments;
the comments must be received in the
Regional Programs Unit within 30 days
following the meeting. Written
comments may be emailed to Brooke
Peery at bpeery@usccr.gov. Persons who
desire additional information may
contact the Regional Programs Unit
Office/Advisory Committee
Management Unit at (202) 701–1376.
Records generated from this meeting
may be inspected and reproduced at the
Regional Programs Unit Office, as they
become available, both before and after
the meeting. Records of the meeting will
be available at: https://
www.facadatabase.gov/FACA/
FACAPublicViewCommitteeDetails?
id=a10t0000001gzkUAAQ.
Please click on the ‘‘Meeting Details’’
and ‘‘Documents’’ links. Persons
interested in the work of this Committee
are also directed to the Commission’s
website, https://www.usccr.gov, or may
contact the Regional Programs Unit
office at the above email address.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:56 Sep 14, 2022
Jkt 256001
Dated: September 9, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
Agenda
I. Welcome & Roll Call
II. Committee Discussion
III. Public Comment
IV. Adjournment
COMMISSION ON CIVIL RIGHTS
[FR Doc. 2022–19897 Filed 9–14–22; 8:45 am]
BILLING CODE 3510–DS–P
Dated: September 12, 2022.
David Mussatt,
Supervisory Chief, Regional Programs Unit.
[FR Doc. 2022–19959 Filed 9–14–22; 8:45 am]
BILLING CODE P
Foreign-Trade Zones Board
[B–42–2022]
Foreign-Trade Zone (FTZ) 153—San
Diego, California, Notification of
Proposed Production Activity,
Ajinomoto Bio-Pharma Services
(Pharmaceutical Products), San Diego,
California
The City of San Diego, grantee of FTZ
153, submitted a notification of
proposed production activity to the FTZ
Board (the Board) on behalf of
Ajinomoto Bio-Pharma Services, located
in San Diego, California under FTZ 153.
The notification conforming to the
requirements of the Board’s regulations
(15 CFR 400.22) was received on
September 7, 2022.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status material(s)/
component(s) and specific finished
product(s) described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz.
The proposed finished product is
yusimry—(active pharmaceutical
ingredient (API) substance and
packaging into measured doses in vials
and/or syringes) (duty-free).
The proposed foreign-status material
and component is yusimry API
substance (duty-free).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
October 25, 2022.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov.
Frm 00007
International Trade Administration
[A–570–042, C–570–043]
DEPARTMENT OF COMMERCE
PO 00000
DEPARTMENT OF COMMERCE
Fmt 4703
Sfmt 4703
Stainless Steel Sheet and Strip From
the People’s Republic of China:
Preliminary Scope Ruling and
Preliminary Affirmative Determination
of Circumvention for Exports From the
Socialist Republic of Vietnam
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The U.S. Department of
Commerce (Commerce) preliminarily
determines that certain stainless steel
sheet and strip (SSSS) of Chinese-origin
that has undergone further processing in
the Socialist Republic of Vietnam
(Vietnam) is merchandise covered by
the scope of the antidumping duty (AD)
and countervailing duty (CVD) orders
on SSSS from the People’s Republic of
China (China). Additionally, Commerce
preliminarily determines that SSSS that
is completed in Vietnam using certain
non-subject stainless steel flat-rolled
inputs sourced from China, is
circumventing the AD/CVD orders on
SSSS from China. As a result, SSSS of
Chinese-origin that has undergone
further processing or completion in
Vietnam will be subject to suspension of
liquidation effective May 15, 2020. We
invite interested parties to comment on
these preliminary determinations.
DATES: Applicable September 15, 2022.
FOR FURTHER INFORMATION CONTACT:
Blaine Wiltse, Office of the Deputy
Assistant Secretary for AD/CVD
Operations, Enforcement and
Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
(202) 482–6345.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On May 15, 2020, Commerce
published in the Federal Register its
self-initiation of country-wide
circumvention and scope inquiries of
the AD and CVD orders on SSSS from
China 1 to determine if imports of SSSS
1 See Stainless Steel Sheet and Strip from the
People’s Republic of China: Antidumping Duty
Order, 82 FR 16160 (April 3, 2017) (AD Order); see
also Stainless Steel Sheet and Strip from the
E:\FR\FM\15SEN1.SGM
15SEN1
]]>Agencies
[Federal Register Volume 87, Number 178 (Thursday, September 15, 2022)]
[Notices]
[Page 56626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19897]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-42-2022]
Foreign-Trade Zone (FTZ) 153--San Diego, California, Notification
of Proposed Production Activity, Ajinomoto Bio-Pharma Services
(Pharmaceutical Products), San Diego, California
The City of San Diego, grantee of FTZ 153, submitted a notification
of proposed production activity to the FTZ Board (the Board) on behalf
of Ajinomoto Bio-Pharma Services, located in San Diego, California
under FTZ 153. The notification conforming to the requirements of the
Board's regulations (15 CFR 400.22) was received on September 7, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz.
The proposed finished product is yusimry--(active pharmaceutical
ingredient (API) substance and packaging into measured doses in vials
and/or syringes) (duty-free).
The proposed foreign-status material and component is yusimry API
substance (duty-free).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is October 25,
2022.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Christopher Wedderburn at
[email protected].
Dated: September 9, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-19897 Filed 9-14-22; 8:45 am]
BILLING CODE 3510-DS-P
